No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs541476769 |
chr12:341088-341089 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs141531568 |
chr12:341123-341124 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs147018295 |
chr12:341127-341128 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs488192 |
chr12:341156-341157 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
5 |
rs147641026 |
chr12:341157-341158 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs528275486 |
chr12:341223-341224 |
Weak transcription Enhancers Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs186521196 |
chr12:341228-341229 |
Weak transcription Enhancers Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs546363636 |
chr12:341237-341238 |
Weak transcription Enhancers Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs565855248 |
chr12:341241-341242 |
Weak transcription Enhancers Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs142212024 |
chr12:341258-341259 |
Weak transcription Enhancers Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs537891055 |
chr12:341266-341267 |
Weak transcription Enhancers Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs548371956 |
chr12:341296-341297 |
Weak transcription Enhancers Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs190979024 |
chr12:341298-341299 |
Weak transcription Enhancers Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs570078889 |
chr12:341343-341344 |
Weak transcription Enhancers Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs143110859 |
chr12:341348-341349 |
Weak transcription Enhancers Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs511230 |
chr12:341376-341377 |
Weak transcription Enhancers Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
17 |
rs3782862 |
chr12:341392-341393 |
Weak transcription Enhancers Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
18 |
rs148221459 |
chr12:341431-341432 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs553569455 |
chr12:341432-341433 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs574918840 |
chr12:341438-341439 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs541933544 |
chr12:341441-341442 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs183827994 |
chr12:341547-341548 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs556774024 |
chr12:341548-341549 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs141188585 |
chr12:341596-341597 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs3782861 |
chr12:341686-341687 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs564063742 |
chr12:341695-341696 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs186757224 |
chr12:341699-341700 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs191434487 |
chr12:341705-341706 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs35788657 |
chr12:341706-341707 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs561574901 |
chr12:341742-341743 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs182809340 |
chr12:341769-341770 |
Weak transcription Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs186712986 |
chr12:341804-341805 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs531260895 |
chr12:341813-341814 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs189610166 |
chr12:341821-341822 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs573129232 |
chr12:341822-341823 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs371698356 |
chr12:341873-341874 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs150301423 |
chr12:341911-341912 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs371569348 |
chr12:341932-341933 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs137935803 |
chr12:341997-341998 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs11615492 |
chr12:342004-342005 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs565276415 |
chr12:342073-342074 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs182144937 |
chr12:342106-342107 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs34077284 |
chr12:342130-342131 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs187913733 |
chr12:342148-342149 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs146923788 |
chr12:342151-342152 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs568681524 |
chr12:342183-342184 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs544605191 |
chr12:342209-342210 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs193092843 |
chr12:342232-342233 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs185297251 |
chr12:342251-342252 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs562705731 |
chr12:342284-342285 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|